Furthermore, we found that decreased activated CD8 T cells, enriched CD4 T cells, and enriched DCs in HCC were associated with poor survival outcomes, severing as risk factors for HCC prognosis (Fig. 7B). The gene discussed is CD8A; the disease is hepatocellular carcinoma.